According to CME Group’s Fedwatch tool, the odds for a September rate cut now stand at 88.2%, compared with 63.3% a week earlier. Market participants expect at least two quarter-point cuts by the end ...

Arteris stock closed at $9.45 on August 4, 2025, representing a 4.42% gain, but the real excitement began in premarket ...

U.S. stock futures advanced early Tuesday, signaling potential follow-through after a strong start to the week. Despite ...

Dow Jones futures appreciate ahead of the US market opening on Tuesday, trading around 44,380, up by 0.17%, during early European hours. Meanwhile, S&P 500 futures surge by 0.25% to 6,370, and Nasdaq ...

Fitch Ratings has downgraded Intel's (NASDAQ:INTC) long-term issuer default rating and senior unsecured ratings to 'BBB' from ...

The strategic combination and interoperability of Arteris’ FlexGen NoC IP with the AMD Infinity Fabric™ interconnect underscores the increasing complexity of modern SoCs and chiplet-based ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

Major U.S. indices ended Monday in the green with the Dow Jones Industrial Average rising 1.3% higher at 44,173.64.

Investing.com-- U.S. stock index futures edged higher on Monday evening after Wall Street staged a sharp rebound, recovering ...

In contrast, ARK showed a bullish stance on Twist Bioscience Corp (NASDAQ: TWST ), purchasing 291,273 shares across ARKK and ...

Stocks surged Monday, led by tech sector gains, as the market recovered from a steep decline at the end of last week that was sparked by renewed concerns about tariffs and the health of the economy.

Adjusted EBITDA (Q4): Adjusted EBITDA loss of $316,000 for Q4 FY2025, substantially narrowed from a $1.7 million adjusted ...